Dador, Mercedita F.
HRN: 22-86-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/26/2024
05/03/2024
IVT
4.5g
Q8
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes